Handbook of Clinical medicine

in pregnancy. Malaria prevention Vector control for all people at risk of malaria. Includes: • Source reduction by destruction of mosquito breeding sites (ie standing water). • Long-lasting insecticidal nets. These should be provided free of charge and with equity of access. Nets last for ~3y, a lifespan of 5y could save ~$3.8bn. Insecticidal resistance is an increasing concern, should dual agents be used? • Indoor residual spraying, eff ective for 3–6 months when >80% of houses included. • Sterile male mosquito release. Estimated to initially require 20 males/human to be protected  ~64 billion sterile mosquitoes worldwide. • Genetic modifi cation to develop mosquitoes that are not susceptible to malaria (and other) parasites. Requires modifi cation that does not  fertility or will not disperse in vector population. Requires acceptability, infrastructure, and money. Chemoprophylaxis is the use of antimalarial drugs to prevent clinical disease. In high-transmission areas it is recommended for pregnant women (given at antena- tal visits) and infants (given with routine vaccination). Travellers from the UK to malaria areas should be given: 1 Bite prevention advice: insect repellents with 20–50% DEET (for all >2 months old including pregnant and breast-feeding). Apply after sunscreen with SPF >30 as
